With the administrative stay from the FDA now in place, we continue to offer our products to adult smokers while we pursue the Agency’s internal review process. We remain confident in the quality and substance of our applications and believe that ultimately we will be able to demonstrate that our products do in fact meet the statutory standard of being appropriate for the protection of the public health. We now look forward to re-engaging with the FDA on a science- and evidence-based process to pursue a marketing authorization for JUUL products.
— Joe Murillo, Chief Regulatory Officer at Juul Labs
August 8, 2025
Juul Labs filed complaints today against NJOY and Altria with the United States International Trade Commission (ITC) and the United States District Court for…
July 17, 2025
Today the U.S. Food and Drug Administration (FDA) issued marketing granted orders (MGOs) for the JUUL System. As part of our 2020 applications, we…
April 30, 2025